We are thrilled to announce that Recursion is setting a new gold standard for the industry with the release of ...

Negative data cost AbbVie billions of dollars in market value and convinced analysts Bristol Myers had placed a better bet in ...

Scientists reprogrammed a woman's fat cells to become insulin-making beta cells, reversing her type 1 diabetes.

Reliance Power, Nykaa, 3M India, Sula Vineyards, BASF India, Natco Pharma, and Rattanindia Enterprises are among other firms ...

Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...

PrivateThe Q2 earnings season has crossed the peak and is now nearing the end of the season. Out of 4699 companies listed on exchanges, 1852 companies have already declared their quarterly financials ...

BTIG analyst Mark Massaro reiterated a Buy rating on MaxCyte (MXCT – Research Report) yesterday and set a price target of $8.00. Mark ...

At the intersection of biology and AI, Somite.ai is pioneering the future of repairing human bodies by applying the predictive power of engineering.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Typically, molecules considered for quantum applications aren’t as big as Buckminsterfullerene. “The overwhelming majority of ...

Few days back, Kazam raised $8 Mn in its Series A3 funding round led by Vertex Ventures Southeast ... as well as alternative materials and chemicals.

Several Philadelphia-area companies gained millions in value following Donald Trump's victory. A Philadelphia retailer, ...